Organic & Biomolecular Chemistry · 2013 · 18 citations · 37 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsLigand-based DesignNatural Product Drug DiscoveryNatural Product-based Drug DesignStructure-activity Relationship AnalysisElectronic Structure EffectsGrowth Inhibition AssaysMitochondrial FragmentationOxygenationPharmacological PotencyPharmacological ProfilingPharmacological SpecificityTherapeutic Growth Inhibition
Natural products of the caged Garcinia xanthones (CGX) family are characterized by a unique chemical structure, potent bioactivities and promising pharmacological profiles. We have developed a Claisen/Diels-Alder reaction cascade that, in combination with a Pd(0)-catalyzed reverse prenylation, provides rapid and efficient access to the CGX pharmacophore, represented by the structure of cluvenone. To further explore this pharmacophore, we have synthesized various A-ring oxygenated analogues of cluvenone and have evaluated their bioactivities in terms of growth inhibition, mitochondrial fragmentation, induction of mitochondrial-dependent cell death and Hsp90 client inhibition. We found that installation of an oxygen functionality at various positions of the A-ring influences significantly both the site-selectivity of the Claisen/Diels-Alder reaction and the bioactivity of these compounds, due to remote electronic effects.
37
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
Adeela Kamal, Lia Thao, John Sensintaffar et al. · Nature · 2003 · 1.4K citations
Medicine, Oncology, Pharmacology +10
Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches
Amie J. McClellan, Yu Xia, Adam M. Deutschbauer et al. · Cell · 2007 · 483 citations · Full text
Dual Roles of PARP-1 Promote Cancer Growth and Progression
Matthew J. Schiewer, Jonathan F. Goodwin, Sumin Han et al. · Cancer Discovery · 2012 · 446 citations · Full text
Medicine, Cancer Biology, Oncology +17